fasudil has been researched along with Colitis in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kangawa, Y | 1 |
| Yoshida, T | 1 |
| Yonezawa, Y | 1 |
| Maruyama, K | 1 |
| Hayashi, SM | 1 |
| Shibutani, M | 1 |
1 other study available for fasudil and Colitis
| Article | Year |
|---|---|
Suppression of epithelial restitution using an inhibitor against Rho-associated coiled-coil containing protein kinase aggravates colitis through reduced epithelial expression of A-kinase anchor protein 13.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; A Kinase Anchor Proteins; Animals; Colitis; Dextran S | 2017 |